publication venue for
- Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition.. 56. 2020
- Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.. 55. 2019
- Comparison of tumor‑targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2.. 54. 2019
- p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.. 52. 2017
- Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.. 52. 2017
- Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression.. 51. 2017
- Dual action of NSC606985 on cell growth and apoptosis mediated through PKCδ in prostatic cancer cells.. 51. 2017
- Dissociation of NSC606985 induces atypical ER-stress and cell death in prostate cancer cells.. 49. 2016
- 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation.. 46. 2014
- Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: a genomic approach.. 42. 2012
- Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells.. 42. 2012
- Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.. 41. 2012
- Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells.. 37. 2010
- Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.. 37. 2010
- JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration.. 37. 2010
- PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells.. 36. 2010
- Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma.. 34. 2009
- Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade.. 34. 2009
- p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.. 31. 2007
- Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2.. 31. 2007
- Reduced lecithin:retinol acyltransferase expression in human breast cancer.. 29. 2006
- Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer.. 28. 2006
- Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses.. 27. 2005
- Retinoid receptor mRNA expression profiles in human bladder cancer specimens.. 26. 2005
- Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.. 26. 2005
- Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.. 25. 2004
- Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.. 25. 2004
- The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach.. 24. 2004
- Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.. 23. 2003
- Selective protection of mitogenically stimulated human lymphocytes but not leukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor.. 19. 2001
- Effects of the novel alphav integrin antagonist SM256 and cis-platinum on growth of murine squamous cell carcinoma PAM LY8.. 16. 2000
- A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer.. 14. 1999
- Aminopeptidase A expression and enzymatic activity in primary human renal cancers.. 13. 1998
- 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.. 12. 1998
- Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.. 12. 1998
- Gene expression of neuropeptide Y and neuropeptide-Y1 receptor in relation to proto-oncogene tyrosine kinase A, nerve-growth-factor low-affinity-receptor and the transcription factor N-myc in human neuroblastomas.. 9. 1996
- Expression and sequence analysis of the SDI1/WAF1/CIP1/p21 tumor suppressor gene in prostate cancer cell lines.. 8. 1996
- Factors associated with p53 nuclear accumulation in prostatic adenocarcinoma.. 4. 1994
- Frameshift and nonsense p53 mutations in squamous-cell carcinoma of head and neck - non-reactivity with 3 anti-p53 monoclonal-antibodies.. 4. 1994
- In-vitro schedule-dependency of eo9 and miltefosine in comparison to standard drugs in colon-cancer cells.. 4. 1994
- Ha-ras codon 12 mutation in papillary tumors of the urinary-bladder - a retrospective study.. 4. 1994
- Ganglioside gd(2) expression in the human nervous-system and in neuroblastomas - an immunohistochemical study.. 3. 1993
- P53 nuclear overexpression and disease progression in ta-bladder carcinoma.. 3. 1993
- Murine hematopoietic ablation by alpha-particle-emitting radiopharmaceuticals - a potential preparative regimen for bone-marrow transplantation.. 2. 1993
- P53 and rb alterations in primary breast-carcinoma - correlation with hormone receptor expression and lymph-node metastases.. 2. 1993
- The androgen receptor and stem cell pathways in prostate and bladder cancers (review). 2011
- Timing of surgery and radiotherapy in the management of metastatic spine disease: a systematic review. 2010
- Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review). 2002
- The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. 1998